Breaking news : Scienta Lab announces its €4M Seed funding to pioneer the AI-powered Precision Immunology revolution [Read more]
Redefining precision immunology
we are modelling immune-mediated inflammatory diseases in an explainable machine learning platform to pave the way for personalized patient care worldwide
Pioneering a data driven approach to drug development and clinical strategies
Clinical trials with highly controlled populations and settings remain the gold standard to evaluate the efficacy of new therapies.
As reliable as these trials are, they fail to capture a key element for predicting real-life effectiveness: individual variability.
In the complex field of immuno-inflammation many factors can influence the clinical benefit of a treatment.
This variability leads to various questions such as
Among all treatments available for rheumatoid arthritis, which one has the highest probability of success for patient x?
Why do some patients with lupus show a very high response of drug y, and others don't?
Which subgroup of patients with Crohn's disease are more likely to benefit from new drug z?
By incorporating our explainable machine learning platform with global medical networks, we are pioneering an innovative data-driven approach to answer these questions.
Partnering with bold visionaries to transform precision medicine in immunology
To realize our mission, we build strategic partnerships with academic centers, researchers and industry leaders at various stages of the drug development, approval and clinical use.
Interested in joining our network of partners ?
A multidisciplinary team of innovators united around a strong vision
Scienta Lab was founded with the conviction that machine learning has the potential to support the develpment of a new paradigm for patients with immuno-inflammatory conditions.
We continue to build a multidisciplinary team of outstanding, curious and honest individuals working passionately towards this goal.